Xiaomin Liu
No. 6 Jizhao Road
Tianjin, 300050, China
Tianjin, 300050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
ARL13B is regulated by the ERK/P90 pathway and mediates TMZ resistance in glioblastoma via microvesicles.
Journal: Scientific reports
Published: December 28, 2025
Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 08, 2025
Combination immunotherapy and anti-angiogenic therapy shows promising efficacy in NSCLC patients with recurrent or refractory brain metastases and negative driver genes.
Journal: Frontiers in immunology
Published: August 13, 2025
Unravelling genomic differences in cerebrospinal fluid: patients with lung cancer with combined brain parenchymal and meningeal metastasis versus exclusive meningeal metastasis.
Journal: Journal of neuro-oncology
Published: July 08, 2025
Development of a fatty acid metabolism (FAM)-related gene signature for prognosis prediction and personalized therapy in lower grade gliomas.
Journal: Translational cancer research
Published: June 20, 2025
Application of AI Chatbot in Responding to Asynchronous Text-Based Messages From Patients With Cancer: Comparative Study.
Journal: Journal of medical Internet research
Published: October 12, 2024
ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway.
Journal: Cancer letters
Published: October 05, 2024
Levetiracetam: A Potent Sword against Microglia Polarization in Gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 13, 2023
RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
Journal: Cell death & disease
Published: October 07, 2023
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
Journal: Cancer letters
Published: October 03, 2023
Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance.
Journal: Cancer biology & medicine
Published: June 07, 2023
Last Updated: 09/26/2026